Suxibuzone
From Wikipedia, the free encyclopedia
 |
|
|
Suxibuzone
|
|
| Systematic (IUPAC) name | |
| 4-[ [4-butyl-3,5-dioxo-1,2-di(phenyl)pyrazolidin-4-yl]methoxy]-4-oxobutanoic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | M02 |
| PubChem | |
| Chemical data | |
| Formula | C24H26N2O6 |
| Mol. mass | 438.47304 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Suxibuzone is a drug used for joint and muscular pain.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||
